Physician profile
Paul E Fracasso
NPI 1891786232
$901.16
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $188 · 2022: $22.19.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $284.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $99.67 | 2019-2020 | |
| Glaxosmithkline, LLC. | $93.45 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $81.83 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $77.87 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $57.35 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.48 | 2019 | |
| Amarin Pharma, INC. | $25.43 | 2019-2020 | |
| Abbott Laboratories | $22.19 | 2022 | |
| Pfizer INC. | $19.82 | 2019 | |
| Lilly USA, LLC | $14.95 | 2020 | |
| Avanir Pharmaceuticals, INC. | $14.85 | 2019 | |
| Mannkind Corporation | $14.76 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.54 | 2019 | |
| Allergan, INC. | $12.42 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.75 | 2019 | |
| Merck Sharp & Dohme LLC | $10.95 | 2019 | |
| Novo Nordisk INC | $10.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Fracasso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.